Global Information
회사소개 | 문의 | 위시리스트

유럽 국가(28개국)의 분자진단 시장 : 매출 예측과 공급업체별 시장 점유율 - 감염증, 유전자 질환, 암, 포렌식 검사, 친자검사 - 경쟁 전략, 의료기기 리뷰, 신기술

A 28-Country Survey of the European Molecular Diagnostics Market: Sales Forecasts and Supplier Shares--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Competitive Strategies, Instrumentation Review, Emerging Technologies

리서치사 Venture Planning Group
발행일 상품 코드 352217
페이지 정보 영문
가격
US $ 24,500 ₩ 29,003,000 DataPack (Local license)
US $ 34,500 ₩ 40,841,000 PDF by E-mail (Local license)
US $ 53,900 ₩ 63,806,000 DataPack (Global license)
US $ 75,900 ₩ 89,850,000 PDF by E-mail (Global license)


유럽 국가(28개국)의 분자진단 시장 : 매출 예측과 공급업체별 시장 점유율 - 감염증, 유전자 질환, 암, 포렌식 검사, 친자검사 - 경쟁 전략, 의료기기 리뷰, 신기술 A 28-Country Survey of the European Molecular Diagnostics Market: Sales Forecasts and Supplier Shares--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Competitive Strategies, Instrumentation Review, Emerging Technologies
발행일 : 페이지 정보 : 영문

유럽 국가(28개국)의 분자진단 시장을 분석했으며, 현재의 기술 개발 및 보급 상황, 주요 검사기기 리뷰, 각종 검사 건수 및 시약 매출 전망, 주요 공급업체 프로파일 및 시장 점유율, 국가별 시장의 상세 동향, 향후 시장 기회와 극복해야 할 과제, 기업이 취해야 할 전략 등에 대해 전해드립니다.

제1장 서론

제2장 주요 제품 개발 기회

  • 검사기기
  • 시약 키트, 검사 시스템/패널
  • 컴퓨터, 소프트웨어, 자동화
  • 보조 제품

제3장 분산 검사 제품 설계 기준

제4장 대체적인 시장 침투 전략

  • 내부개발
  • 합작투자 협정
  • 대학과의 계약
  • 분산 검사 시장의 유통 전략

제5장 잠재적인 시장 진출 장벽과 위험

  • 시장 성숙화
  • 비용 억제
  • 경쟁
  • 최첨단 기술과 한계
  • 특허 보호
  • 규제에 의한 억제
  • 분산 검사 시장이 해결해야 할 과제

제6장 세계 시장과 기술 분석

  • DNA 시퀀싱
  • DNA 및 RNA 프로브 기술
  • 검출 기술
  • 분자진단 장비 리뷰(총 25개사)
  • 바이오칩 : Genosensors, Microarrays, Labs-on-the-Chip
  • 약물유전체학(Pharmacogenomics)
  • 주요 용도
    • 미생물학/감염증 검사
    • 암검사
    • 유전자 질환
    • 포렌식 검사
    • 친자검사/HLA형 판정
    • 기타 용도
  • 경쟁 기술 및 보완 기술

제7장 국가별 분석 : 검사 건수 및 매출 예측 - 감염증, 유전자 질환, 암, 포렌식 검사, 친자검사

  • 오스트리아
  • 벨기에
  • 불가리아
  • 체코
  • 덴마크
  • 에스토니아
  • 핀란드
  • 프랑스
  • 독일
  • 그리스
  • 헝가리
  • 아이슬란드
  • 아일랜드
  • 이탈리아
  • 라트비아
  • 리투아니아
  • 몰타
  • 네덜란드
  • 노르웨이
  • 폴란드
  • 포르투갈
  • 루마니아
  • 슬로바키아
  • 슬로베니아
  • 스페인
  • 스웨덴
  • 스위스
  • 영국

제8장 경쟁사 평가

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken Chemical
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio Inc.
  • Tecan Group

제9장 부록 : 분자진단 기술 및 제품 신규 개발에 참여하고 있는 대학 및 연구기관

도표

LSH 16.03.02

This new 28-country survey from VPGMarketResearch.com contains over 1,150 pages, 213 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

  • Supplier sales and market shares in major countries
  • Five-year test volume and sales forecasts
  • Strategic profiles of market players and start-up firms developing innovative technologies and products
  • Emerging technologies
  • Review of molecular diagnostic analyzers
  • Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK

Market Segmentation Analysis

  • Sales and market shares of key suppliers of molecular diagnostic reagent kits and components in major markets.
  • Five-year test volume and sales forecasts for major applications, including:
    • Infectious Diseases        &nbsp &nbsp - Forensic Testing
      &nbsp &nbsp - Cancer&nbsp               &nbsp                  &nbsp - Paternity Testing/HLA Typing
      &nbsp &nbsp - Genetic Diseases             &nbsp &nbsp - Others
  • Five-year test volume and sales projections for over 30 NAT assays.
  • Analysis of the sequencing market, including:
    • Industrial
    • Academic
    • Government
    • Commercial
  • Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.

Product/Technology Review

  • Comparison of leading molecular diagnostic ;analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.
  • Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
    • PCR
    • bDNA
    • NASBA
    • SSSR, and others.
    • LCR
  • Universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

  • Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
  • Companies developing and marketing molecular diagnostics products, by test and application.

Opportunities and Strategic Recommendations

  • Specific new product development opportunities with potentially significant market appeal during the next five years.
  • Design criteria for new products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains: 1,150 pages and 213 tables.

Table of Contents

I. Introduction

II. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets

V. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VI. Worldwide Market and Technology Review

  • A. DNA Sequencing
    • 1. Introduction
    • 2. Sequencing Methods
    • 3. Autoradiography
    • 4. The Human Genome Project
    • 5. Sequencing Automation
    • 6. Image Scanners
    • 7. Fluorescent Detection
    • 8. Gene Profiling
    • 9. Gene Expression
    • 10. Polymorphism Screening
    • 11. Protein Interaction Networks
  • B. DNA and RNA Probe Technologies
    • 1. Basic Principles
    • 2. Probe Preparation
    • 3. The DNA Probe Test
    • 4. Test Formats
    • 5. Labeling Techniques
    • 6. Amplification Methods
  • C. Detection Technologies
    • 1. Radioactive Methods
      • a. Overview
      • b. Major Isotopes
    • 2. Non-Isotopic Methods
      • a. Enzymatic Labels
      • b. Chemical Labeling
      • c. Fluorescence
      • d. Chemiluminescence
      • e. Electrical Conductivity
  • D. Molecular Diagnostic Instrumentation Review
    • 1. Abbott LCx
    • 2. Beckman Coulter/Biomek FK
    • 3. BD Viper System with XTR Technology
    • 4. BD Innova
    • 5. Becton Dickinson SDA
    • 6. bioMerieux NucliSENS easyMAG
    • 7. bioMerieux NucliSENS easyQ and MiniMAG
    • 8. Bio-Rad GeneScope
    • 9. Cepheid GeneXpert
    • 10. Curetis Unyvero
    • 11. GenMark Dx eSensor XT-8
    • 12. Hologic/Gen-Probe Panther
    • 13. Hologic/Gen-Probe Tigris/DTS
    • 14. HTG Molecular Edge
    • 15. Life Technologies QuantStudio Dx
    • 16. Qiagen QIAsymphony RGQ
    • 17. Roche Cobas Amplicor
    • 18. Roche Cobas TaqMan 48
    • 19. Roche Cobas TaqMan
    • 20. Roche Cobas TaqMan AmpliPrep
    • 21. Roche LighCycler 480
    • 22. Roche Cobas 4800
    • 23. Roche Cobas s 201
    • 24. Siemens Versant
    • 25. Tecan LS Series
  • E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
    • Liquid Transportation and Mixing
    • Separation
    • Reaction
    • Detection
  • F. Pharmacogenomics
  • G. Major Applications
    • 1. Microbiology/Infectious Diseases
      • a. Overview
      • b. Major Infectious Diseases
        • AIDS/HIV
        • Adenovirus
        • Aeromonads
        • Anthrax/Bacillus Anthracis
        • Arboviruses
        • Babesiosis
        • Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
        • Blastocystis Hominis
        • Brucella
        • Campylobacter
        • Candida
        • Chagas Disease
        • Chancroid
        • Chlamydia
        • Clostridium Difficile
        • Coronaviruses
        • Coxsackieviruses
        • Creutzfeldt-Jakob's Disease
        • Cryptosporidium Parvum
        • Cyclospora Cayetanensis
        • Cytomegalovirus
        • Ebola Virus
        • E. Coli
        • Echovirus
        • Encephalitis
        • Enteroviruses
        • Epstein-Barr Virus
        • Giardia Lamblia
        • Gonorrhea
        • Granuloma Inguinale
        • Hantavirus
        • Helicobacter Pylori
        • Hepatitis
        • Herpes Simplex Virus
        • Human Herpes Virus-6 (HHV-6)
        • Influenza Viruses
        • Legionella
        • Lyme Disease
        • Lymphogranuloma Venereum (LGV)
        • Malaria
        • Measles (Rubeola)
        • Meningitis
        • Microsporidium
        • Mononucleosis
        • Mumps
        • Mycoplasma
        • Papillomaviruses
        • Parvovirus B19
        • Pneumonia
        • Polyomaviruses
        • Pseudomonas Aeruginosa
        • Rabies
        • Respiratory Syncytial Virus (RSV)
        • Rhinoviruses
        • Rotavirus
        • Rubella
        • Salmonellosis
        • Septicemia
        • Shigellosis
        • Staphylococcus Aureus
        • Streptococci
        • Syphilis
        • Toxoplasmosis
        • Trichomonas Vaginalis
        • Tuberculosis
        • Vibrio
        • West Nile Virus
        • Yersinia
    • 2. Cancer Testing
      • a. Overview
      • b. Major Cancer Types
        • Prostate
        • Lung
        • Colon and Rectum
        • Breast
        • Skin
        • Uterine
        • Leukemia
        • Oral
      • c. Oncogenes
        • Abl/abl-bcr
        • AIB1
        • BCL-2
        • BRCA1
        • CD44
        • C-fos
        • C-myb
        • C-myc
        • CYP17
        • Erb-B
        • HPC1
        • N-myc
        • P40
        • P51
        • P53
        • PIK3CA
        • PTI-1
        • Ras
        • Reg
        • Sis
        • Src
    • 3. Genetic Diseases
      • a. Overview
      • b. Nucleic Acid Amplification
      • c. Chromosome Imaging
      • d. Genomics Technologies
      • e. Proteomics Technologies
      • f. Current Pharmacogenomic Tests
      • g. Future Pharmacogenomic Testing
      • h. Major Diseases
        • Achondroplasia
        • Autosomal Dominant Polycystic Kidney Disease
        • Cancer
        • Cosmetogenomics
        • Cystic Fibrosis
        • Down's Syndrome
        • Duchenne and Becker Muscular Dystrophy
        • Factor V (Leiden)
        • Factor IX Deficiency
        • Fragile X Syndrome
        • Heart Disease
        • Hemochomatosis
        • Hemophilia
        • Huntington's Disease
        • Maternal-Fetal Incompatibility
        • Multiple Endocrine Neoplasia
        • Phenylketonuria (PKU)
        • Polycystic Kidney Disease (PKD)
        • Prenatal Screening
        • Retinitis Pigmentosa
        • Retinoblastoma
        • Sickle Cell Anemia
        • Spinal Muscular Atrophy
        • Vitamin B12 Metabolism
      • i. Social Issues and Concerns
    • 4. Forensic Testing
      • a. Overview
      • b. Multilocus and Single Locus Probes
      • c. DNA Profile Data Banks
      • d. Judicial Implementation
      • e. Major Crime Categories
      • f. Factors Contributing to the DNA Probe Market Expansion
        • Technology Availability
        • Use of Hair as Evidence
      • g. Wildlife Forensics
    • 5. Paternity Testing/HLA Typing
    • 6. Other Applications
      • a. Disease Susceptibility Testing
      • b. Cardiovascular Diseases
      • c. Diabetes
      • d. Alzheimer's Disease
      • e. Periodontal Disease
      • f. Plasma Purification
      • g. Organ Transplantation
      • h. Water Contamination
      • i. Other
  • H. Competing/complementing
    • 1. Monoclonal Antibodies/Immunoassays
    • 2. RNA Probes
    • 3. Two-Dimensional Electrophoresis
    • 4. Flow Cytometry

VII. Country Analyses: Volume and Sales Forecasts--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

  • Austria
  • Belgium
  • Bulgaria
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • UK

VIII. Competitive Assessments

  • Abbott
  • Affymetrix/Thermo Fisher
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

IX. Appendix: Major Universities and Research Centers Developing Innovative Molecular Diagnostic Technologies and Products

List of Tables

  • Austria
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Austria
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Austria
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Austria
  • Molecular Diagnostics Market Forecasts by Application
  • Austria
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Belgium
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Belgium
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Belgium
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Belgium
  • Molecular Diagnostics Market Forecasts by Application
  • Belgium
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Bulgaria
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Bulgaria
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Bulgaria
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Bulgaria
  • Molecular Diagnostics Market Forecasts by Application
  • Bulgaria
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Czech Republic
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Czech Republic
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Czech Republic
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Czech Republic
  • Molecular Diagnostics Market Forecasts by Application
  • Czech Republic
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Denmark
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Denmark
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Denmark
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Denmark
  • Molecular Diagnostics Market Forecasts by Application
  • Denmark
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Estonia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Estonia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Estonia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Estonia
  • Molecular Diagnostics Market Forecasts by Application
  • Estonia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Finland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Finland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Finland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Finland
  • Molecular Diagnostics Market Forecasts by Application
  • Finland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • France
  • Molecular Diagnostics Test Volume and Sales by Major Application
  • France
  • Laboratories Performing DNA Sequencing by Market Segment
  • France
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • France
  • Molecular Diagnostics Test Volume by Major Application
  • France
  • Major Infectious Disease Test Volume by Assay
  • France
  • Major Infectious Disease Test Volume by Method
  • France
  • Molecular Diagnostics Market by Major Application
  • France
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • France
  • Major Infectious Disease Diagnostics Market by Assay
  • France
  • AIDS Testing Market Estimated Sales by Major Supplier
  • France
  • Adenovirus Testing Market Estimated Sales by Major Supplier
  • France
  • Chlamydia Testing Market Estimated Sales by Major Supplier
  • France
  • CMV Testing Market Estimated Sales by Major Supplier
  • France
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • France
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • France
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • France
  • HIV/Hepatitis Blood Screening
  • NAT Market Reagent Sales by Major Supplier
  • France
  • Herpes Testing Market Estimated Sales by Major Supplier
  • France
  • Influenza Testing Market Estimated Sales by Major Supplier
  • France
  • Meningitis Testing Market Estimated Sales by Major Supplier
  • France
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • France
  • RSV Testing Market Estimated Sales by Major Supplier
  • France
  • Shigella Testing Market Estimated Sales by Major Supplier
  • Germany
  • Molecular Diagnostics
  • Test Volume and Sales by Major Application
  • Germany
  • Laboratories Performing DNA Sequencing by Market Segment
  • Germany
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Germany
  • Molecular Diagnostics Test Volume by Major Application
  • Germany
  • Major Infectious Disease Test Volume by Assay
  • Germany
  • Major Infectious Disease Test Volume by Method
  • Germany
  • Molecular Diagnostics Market by Major Application
  • Germany
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • Germany
  • Major Infectious Disease Diagnostics Market by Assay
  • Germany
  • AIDS Testing Market Estimated Sales by Major Supplier
  • Germany
  • CMV Testing Market Estimated Sales by Major Supplier
  • Germany
  • EBV Testing Market Estimated Sales by Major Supplier
  • Germany
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Germany
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • Germany
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Germany
  • HIV/Hepatitis Blood Screening
  • NAT Market Reagent Sales by Major Supplier
  • Germany
  • Herpes Testing Market Estimated Sales by Major Supplier
  • Germany
  • Influenza Testing Market Estimated Sales by Major Supplier
  • Germany
  • Meningitis Testing Market Estimated Sales by Major Supplier
  • Germany
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Germany
  • Pneumonia Testing Market Estimated Sales by Major Supplier
  • Germany
  • RSV Testing Market Estimated Sales by Major Supplier
  • Germany
  • Rotavirus Testing Market Estimated Sales by Major Supplier
  • Greece
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Greece
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Greece
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Greece
  • Molecular Diagnostics Market Forecasts by Application
  • Greece
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Hungary
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Hungary
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Hungary
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Hungary
  • Molecular Diagnostics Market Forecasts by Application
  • Hungary
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Iceland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Iceland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Iceland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Iceland
  • Molecular Diagnostics Market Forecasts by Application
  • Iceland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Ireland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Ireland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Ireland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Ireland
  • Molecular Diagnostics Market Forecasts by Application
  • Ireland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Italy
  • Molecular Diagnostics Test Volume and Sales by Major Application
  • Italy
  • Laboratories Performing DNA Sequencing by Market Segment
  • Italy
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Italy
  • Molecular Diagnostics Test Volume by Major Application
  • Italy
  • Major Infectious Disease Test Volume by Assay
  • Italy
  • Major Infectious Disease Test Volume by Method
  • Italy
  • Molecular Diagnostics Market by Major Application
  • Italy
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • Italy
  • Major Infectious Disease Diagnostics Market by Assay
  • Italy
  • AIDS Testing Market Estimated Sales by Major Supplier
  • Italy
  • CMV Testing Market Estimated Sales by Major Supplier
  • Italy
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Italy
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • Italy
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Italy
  • HIV/Hepatitis Blood Screening
  • NAT Market Reagent Sales by Major Supplier
  • Italy
  • Herpes Testing Market Estimated Sales by Major Supplier
  • Italy
  • Influenza Testing Market Estimated Sales by Major Supplier
  • Italy
  • Meningitis Testing Market Estimated Sales by Major Supplier
  • Italy
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Italy
  • RSV Testing Market Estimated Sales by Major Supplier
  • Latvia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Latvia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Latvia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Latvia
  • Molecular Diagnostics Market Forecasts by Application
  • Latvia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Lithuania
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Lithuania
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Lithuania
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Lithuania
  • Molecular Diagnostics Market Forecasts by Application
  • Lithuania
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Malta
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Malta
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Malta
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Malta
  • Molecular Diagnostics Market Forecasts by Application
  • Malta
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Netherlands
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Netherlands
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Netherlands
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Netherlands
  • Molecular Diagnostics Market Forecasts by Application
  • Netherlands
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Norway
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Norway
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Norway
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Norway
  • Molecular Diagnostics Market Forecasts by Application
  • Norway
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Poland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Poland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Poland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Poland
  • Molecular Diagnostics Market Forecasts by Application
  • Poland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Portugal
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Portugal
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Portugal
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Portugal
  • Molecular Diagnostics Market Forecasts by Application
  • Portugal
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Romania
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Romania
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Romania
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Romania
  • Molecular Diagnostics Market Forecasts by Application
  • Romania
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Slovakia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Slovakia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Slovakia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Slovakia
  • Molecular Diagnostics Market Forecasts by Application
  • Slovakia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Slovenia
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Slovenia
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Slovenia
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Slovenia
  • Molecular Diagnostics Market Forecasts by Application
  • Slovenia
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Spain
  • Molecular Diagnostics Test Volume and Sales by Major Application
  • Spain
  • Laboratories Performing DNA Sequencing by Market Segment
  • Spain
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Spain
  • Molecular Diagnostics Test Volume by Major Application
  • Spain
  • Major Infectious Disease Test Volume by Assay
  • Spain
  • Major Infectious Disease Test Volume by Method
  • Spain
  • Molecular Diagnostics Market by Major Application
  • Spain
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • Spain
  • Major Infectious Disease Diagnostics Market by Assay
  • Spain
  • AIDS Testing Market Estimated Sales by Major Supplier
  • Spain
  • Chlamydia Testing Market Estimated Sales by Major Supplier
  • Spain
  • CMV Testing Market Estimated Sales by Major Supplier
  • Spain
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • Spain
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • Spain
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • Spain
  • HIV/Hepatitis Blood Screening
  • NAT Market Reagent Sales by Major Supplier
  • Spain
  • Herpes Testing Market Estimated Sales by Major Supplier
  • Spain
  • Influenza Testing Market Estimated Sales by Major Supplier
  • Spain
  • Meningitis Testing Market Estimated Sales by Major Supplier
  • Spain
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • Sweden
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Sweden
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Sweden
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Sweden
  • Molecular Diagnostics Market Forecasts by Application
  • Sweden
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • Switzerland
  • Molecular Diagnostics Test Volume and Sales Forecasts by Application
  • Switzerland
  • Molecular Diagnostics Test Volume Forecasts by Application
  • Switzerland
  • Major Infectious Disease Test Volume Forecasts by Assay
  • Switzerland
  • Molecular Diagnostics Market Forecasts by Application
  • Switzerland
  • Major Infectious Disease Diagnostics Market Forecasts by Assay
  • U.K.
  • Molecular Diagnostics Test Volume and Sales by Major Application
  • U.K.
  • Laboratories Performing DNA Sequencing by Market Segment
  • U.K.
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • U.K.
  • Molecular Diagnostics Test Volume by Major Application
  • U.K.
  • Major Infectious Disease Test Volume by Assay
  • U.K.
  • Major Infectious Disease Test Volume by Method
  • U.K.
  • Molecular Diagnostics Market by Major Application
  • U.K.
  • Molecular Diagnostics Market
  • Estimated Sales and Market Shares of Major Suppliers
  • U.K.
  • Major Infectious Disease Diagnostics Market by Assay
  • U.K.
  • AIDS Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Gonorrhea Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Hepatitis Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Hepatitis C Testing Market Estimated Sales by Major Supplier
  • U.K.
  • HIV/Hepatitis Blood Screening NAT Market
  • Reagent Sales by Major Supplier
  • U.K.
  • Influenza Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Mycoplasma Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Pneumonia Testing Market Estimated Sales by Major Supplier
  • U.K.
  • Shigella Testing Market Estimated Sales by Major Supplier
  • Major Companies Developing or Marketing AIDS Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Bartonella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Candida
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Clostridium
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Coronavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Cryptosporidium
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Echovirus Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Enterovirus Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Giardia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Hantavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Helicobacter
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Influenza
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme
  • Disease Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Measles
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Meningitis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mononucleosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mumps
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing RSV
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Rotavirus
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Rubella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Septicemia
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Syphilis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Trichomonas
  • Molecular Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis
  • Molecular Diagnostic and Other Direct Identification Tests
  • Oncogenes Potential Application in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer
  • Molecular Diagnostic Tests
  • Major Companies Developing or Marketing Molecular
  • Diagnostic Tests for Genetic Diseases
Back to Top
전화 문의
F A Q